Drug intelligence / Profile preview

soy isoflavone

Development stage
Unknown
Lead developer
National Center for Complementary and Integrative Health
Modality
Small Molecules
Administration
Oral
01

Overview

Soy isoflavones are naturally occurring plant-derived compounds, specifically phytoestrogens, that are being investigated by the National Center for Complementary and Integrative Health (NCCIH) for their potential health benefits. The primary active ingredients are the small molecule isoflavones genistein, daidzein, and glycitein. These compounds are structurally similar to 17β-estradiol and function as selective estrogen receptor modulators (SERMs). They bind to both estrogen receptor alpha (ER-α) and estrogen receptor beta (ER-β), with a significantly higher affinity for ER-β. In clinical research, such as the Phase 2 trial NCT00200824, these isoflavones are studied for their ability to influence surrogate markers of breast and prostate cancer, as well as their impact on bone mineral density and quality of life in postmenopausal women and men undergoing androgen ablation therapy. As a nutraceutical product rather than a regulated pharmaceutical, soy isoflavones represent a dietary approach to managing hormone-sensitive conditions and bone health.

Other names
soy isoflavonesphytoestrogensgenisteindaidzeinglycitein
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on soy isoflavone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soy isoflavone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call